Year: 2022
-
The role of Olig2 transcription factor in striosome development, function, and X-linked dystonia parkinsonism
-
Cell-based screening of chemical compounds countering XDP-SVA mediated disruption of TAF1 mRNA biosynthesis
-
Somatic repeat instability as a modifier of XDP pathogenesis
-
Identify disease targets and perturbagens that modulate XDP-disease phenotypes with robotic microscopy, deep learning and OMICS in human in vitro XDP cell models
-
Epigenetic regulation of the XDP-SVA and its link to XDP pathology
-
A Drosophila Taf1 knockdown model for rapid testing of genetic interactions and therapeutic interventions
-
Understanding pathophysiology in XDP using mosaicism
-
Molecular Mechanism and Therapeutic Targets of X-Linked Dystonia Parkinsonism
-
Phenotypic analysis of a conditional humanize mouse mode of XDP
-
Phenotyping novel engineered XDP/TAF1 mice at the behavioral and cell level